Optimized production and purification of Bacillus anthracis lethal factor

Protein Expression and Purification

Volumn 18, Issue 3, 2000, Pages 293-302

  Park, Sukjoon ^a   Leppla, Stephen H ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL SEQUENCE; CHROMATOGRAPHY; CRYSTAL STRUCTURE; CRYSTALLIZATION; CULTURE MEDIUM; GENE MUTATION; HYBRID PROTEIN; METALLOPROTEINASE; PROMOTER REGION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; SHUTTLE VECTOR; SIGNAL PEPTIDE; VIRULENCE; WILD RELATIVE;

ANTHRAX; BACILLUS ANTHRACIS; COLI BACILLUS; ESCHERICHIA COLI;

EID: 0034049623     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2000.1208     Document Type: Article

References (36)

1. Keppie J., Harris-Smith P. W., Smith H. The chemical basis of the virulence of Bacillus anthracis. IX. Its aggressins and their mode of action. Br. J. Exp. Pathol. 44:1963;446-453.
2. Friedlander A. M. Anthrax. Kelley W. N. Textbook of Internal Medicine. 1997;1508-1510 Lippincott-Raven, Philadelphia.
3. Leppla S. H. The bifactorial Bacillus anthracis lethal and oedema toxins. Alouf J. E., Freer J. H. Comprehensive Sourcebook of Bacterial Protein Toxins. 1999;243-263 Academic Press, London.
4. Leppla S. H. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA. 79:1982;3162-3166.
5. Duesbery N. S., Webb C. P., Leppla S. H., Gordon V. M., Klimpel K. R., Copeland T. D., Ahn N. G., Oskarsson M. K., Fukasawa K., Paull K. D., Vande Woude G. F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 280:1998;734-737.
6. Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M., Montecucco C. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:1998;706-711.
7. Ivins B. E., Pitt M. M., Fellows P. F., Farchaus J. W., Benner G. E., Waag D. M., Little S. F., Anderson G. W., Gibbs P. H., Friedlander A. M. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine. 16:1998;1141-1148.
8. Pezard C., Weber M., Sirard J. C., Berche P., Mock M. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect. Immun. 63:1995;1369-1372.
9. Vodkin M. H., Leppla S. H. Cloning of the protective antigen gene of Bacillus anthracis. Cell. 34:1983;693-697.
10. Robertson D. L., Leppla S. H. Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene. 44:1986;71-78.
11. Tippetts M. T., Robertson D. L. Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: A calmodulin-dependent adenylate cyclase. J. Bacteriol. 170:1988;2263-2266.
12. Welkos S. L., Lowe J. R., Eden-McCutchan F., Vodkin M., Leppla S. H., Schmidt J. J. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene. 69:1988;287-300.
13. Escuyer V., Duflot E., Sezer O., Danchin A., Mock M. Structural homology between virulence-associated bacterial adenylate cyclases. Gene. 71:1988;293-298.
14. Robertson D. L., Tippetts M. T., Leppla S. H. Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): A calmodulin-dependent adenylate cyclase. Gene. 73:1988;363-371.
15. Bragg T. S., Robertson D. L. Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. Gene. 81:1989;45-54.
16. Gladstone G. P. Immunity to anthrax. Protective antigen present in cell-free culture filtrates. Br. J. Exp. Pathol. 27:1946;349-418.
17. Bartkus J. M., Leppla S. H. Transcriptional regulation of the protective antigen gene of Bacillus anthracis. Infect. Immun. 57:1989;2295-2300.
18. Uchida I., Hornung J. M., Thorne C. B., Klimpel K. R., Leppla S. H. Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis. J. Bacteriol. 175:1993;5329-5338.
19. Koehler T. M., Dai Z., Kaufman-Yarbray M. Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters. J. Bacteriol. 176:1994;586-595.
20. Dai Z., Sirard J. C., Mock M., Koehler T. M. The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence. Mol. Microbiol. 16:1995;1171-1181.
21. Fawell S., Seery J., Daikh Y., Moore C., Chen L. L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA. 91:1994;664-668.
22. Puziss M., Manning L. C., Lynch J. W., Barclay E., Abelow I., Wright G. G. Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures. Appl. Microbiol. 11:1963;330-334.
23. Leppla S. H. Purification and characterization of adenylyl cyclase from Bacillus anthracis. Johnson R. A., Corbin J. D. Methods in Enzymology. 1991;153-168 Academic Press, San Diego.
24. Leppla S. H. Production and purification of anthrax toxin. Harshman S. Methods in Enzymology. 1988;103-116 Academic Press, Orlando.
25. Leppla S. H. Anthrax toxin. Aktories K., Just I. Bacterial Protein Toxins. 2000;Springer, Berlin.
26. Petosa C., Collier R. J., Klimpel K. R., Leppla S. H., Liddington R. C. Crystal structure of the anthrax toxin protective antigen. Nature. 385:1997;833-838.
27. Singh Y., Chaudhary V. K., Leppla S. H. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. J. Biol. Chem. 264:1989;19103-19107.
28. Leppla S. H. Anthrax toxins. Moss J., Iglewski B., Vaughan M., Tu A. Bacterial Toxins and Virulence Factors in Disease. Handbook of Natural Toxins. 1995;543-572 Dekker, New York.
29. Quinn C. P., Dancer B. N. Transformation of vegetative cells of Bacillus anthracis with plasmid DNA. J. Gen. Microbiol. 136:1990;1211-1215.
30. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 2:1965;235-254.
31. Varughese M., Chi A., Teixeira A. V., Nicholls P. J., Keith J. M., Leppla S. H. Internalization of a Bacillus anthracis protective antigen c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol. Med. 4:1998;87-95.
32. Klimpel K. R., Arora N., Leppla S. H. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1994;1093-1100.
33. Ivins B. E., Welkos S. L. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis. Infect. Immun. 54:1986;537-542.
34. Marrero R., Welkos S. L. The transformation frequency of plasmids into Bacillus anthracis is affected by adenine methylation. Gene. 152:1995;75-78.
35. Bron S., Bolhuis A., Tjalsma H., Holsappel S., Venema G., van Dijl J. M. Protein secretion and possible roles for multiple signal peptidases for precursor processing in bacilli. J. Biotechnol. 64:1998;3-13.
36. Tjalsma H., Noback M. A., Bron S., Venema G., Yamane K., van Dijl J. M. Bacillus subtilis contains four closely related type I signal peptidases with overlapping substrate specificities. Constitutive and temporally controlled expression of different sip genes. J. Biol. Chem. 272:1997;25983-25992.